Chest Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


COPYRIGHT © 2007 by the American College of Chest Physicians.
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hecker, E.
Right arrow Articles by Welcker, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hecker, E.
Right arrow Articles by Welcker, K.

Thoracic Surgery: Role in Infection


Monday, October 22, 2007

10:30 AM - 12:00 PM

VIDEO-ASSISTED THORACOSCOPY AS A STANDARD TREATMENT IN PARAPNEUMONIC EMPYEMAS

Erich Hecker, MD, FCCP*, Holger Hoefken, MD, Shadi Hamouri, MD and Katrin Welcker, MD

Klinikum Bremen-Ost, Bremen, Germany

PURPOSE: Para pneumonic empyma is a life threatening disease that needs a primary treatment with high cure rate and efficacy.

METHODS: All our patients who diagnosed to have pleura empyema had a pre-operative computed tomography CT scan of the chest before they managed by surgical intervention in terms of video-assisted thoracoscopy (VATS). The type of the procedure used in the treatment correlated with stage of empyema. In all patients the treatment includes intrapleural pus evacuation, surgical debreidment of the thick fibrinous loculations and post-operative once daily irrigation by 1 litre lactated Ringer's solution for 1 week. In stage II patients sometimes decortications of the visceral pleura was necessary where as decortications of the visceral and parietal pleurae is the method of choice in the treatment of stage III. The irrigation is discontinued and the chest tubes removed after 3 negative plural fluid cultures that are performed from the 8th till 10th post operative day. Antibiotics were used only if there is a CT scan evidence of pneumonia.

RESULTS: From 2003 till 2006, one hundred ninety five empyema patients were operated upon. In stage I there were 17 patients who had a therapy success rate of 87.5 % and an average hospital stay of 22 days. 160 patients were found to have stage II disease and the success rate of treatment was 70.6% and an average hospitalisation of 23days where as in stage III were 87.5% and 26 days respectively. In stage II subgroup 35 patients underwent a second revision by thoracoscopy after which all of them cured.4 open thoracotomy revisions were done in stage III group. Thirty three patients (16 from the revision group) died due sepsis and Multi organ failure syndrome (MOFS).

CONCLUSION: VATS is a feasible, effective method to treat all empyema patients in different stages.

CLINICAL IMPLICATIONS: In our centre we recommend VATS procedure primarily for all empyema patients.

DISCLOSURE: Erich Hecker, No Financial Disclosure Information; No Product/Research Disclosure Information







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American College of Chest Physicians.